Law360, New York (September 29, 2009) -- Following more than a decade of litigation, Boston Scientific Corp. has agreed to fork over a whopping $716 million to Johnson & Johnson unit Cordis Corp. to settle more than a dozen lawsuits over stent technology.
Boston Scientific on Tuesday revealed the settlement of the long-running dispute with Cordis, which includes the Palmaz-Nir suit, as well as a few other cardiology-related cases relating to patents in...
